Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-060346

Urovant Sciences Ltd. · UROV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Oct 1, 2018
Accepted (ET)
Oct 3, 2018 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001740547

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Shares, $0.000037453 par value per shareF1,F2Oct 1, 2018P2,678,571$14.00A22,703,669ISee footnote.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses